JP6537897B2 - Drug emission device - Google Patents

Description

  TECHNICAL FIELD The present invention relates to an agent diffusion device for emitting agents such as pest control agents into the air, and more particularly to the technical field of emitting agents by blowing air using an electric motor.

  As this kind of drug diffusion device, one configured to dissipate the drug held by the drug holder by a fan driven by an electric motor is known (see, for example, Patent Documents 1 to 3). ).

  In the inside of the case of Patent Document 1, in addition to the drug holding body and the electric motor, a battery for supplying power to the electric motor is accommodated. The case comprises an upper body and a lower body, and the upper body is removably attached to the lower body. It is possible to replace the drug carrier by removing the upper body from the lower body.

  Further, in Patent Document 2, a cover formed so as to cover the drug support is provided on the case main body for housing the electric motor and the battery, and the replacement work of the drug support is realized by removing the cover from the case main body. It can be done. Further, on the outer surface of the case main body, a power switch is provided for switching between a state of supplying power to the electric motor and a state of not supplying power.

  Further, the drug diffusion device of Patent Document 3 also has a structure in which the drug holder can be replaced by removing the cover from the case main body as in Patent Document 2. In patent document 3, the board | substrate with which the indicator for alerting | reporting the operation state of a chemical | medical agent diffusion apparatus was equipped is provided, This board | substrate is accommodated in the inside of a case main body.

JP, 2013-13421, A Unexamined-Japanese-Patent No. 2004-229664 JP 2005-218305 A

  By the way, in the case of a device that dissipates medicine by a fan driven by an electric motor, a power switch is provided as in Patent Document 2, and power can be turned off when unnecessary. There is. Further, as in Patent Document 3, there is also a demand for providing an indicator (light emitter) or the like for notifying surrounding people of whether or not the power is on.

  In Patent Document 2, since the power switch is provided on a part of the front of the device body, the cover is compact so as not to cover the power switch, whereby the power switch can be operated without removing the cover. It is possible.

  However, for example, as in the case of using the drug delivery device on a human body, there is a demand to miniaturize the drug delivery device. However, in order to obtain sufficient drug efficacy, the drug carrier should be made as large as possible, and a large amount of air is sent to the drug carrier per unit time, so that the drug carrier is covered. The cover gets larger. That is, since the device body is miniaturized and the cover is enlarged, when the power switch is provided on the device body as in Patent Document 2, the cover becomes an obstacle and the operability of the power switch is deteriorated. The switching operation of ON / OFF by means becomes complicated. In addition, it is conceivable that the visibility of the power switch is deteriorated and it is difficult to check the state of the power switch.

  In the case of providing a light emitter for notifying whether or not the power is on as in Patent Document 3, similarly, it is conceivable that the cover becomes an obstacle and the visibility deteriorates.

  That is, there is a demand that the power switch should be placed in a position where it is easy to operate as much as possible in the main body of the drug diffusion device, and there is a demand to place the light emitter in a location with as high visibility as possible. There are only a few places where you can Therefore, a great restriction arises in the arrangement of the substrate on which the power switch and the light emitter are mounted. For this reason, in the device main body of the drug diffusion device, the layout of the battery and the motor which must be disposed so as not to interfere with the substrate is greatly restricted, and there is a problem that the degree of freedom in design is low. In addition, there is a problem that the size of the apparatus body is increased in order to secure the arrangement space of the substrate.

  The present invention has been made in view of such a point, and the object of the present invention is to miniaturize the device main body, to improve the operability and visibility of the power switch, and to provide a light emitter. The object of the present invention is to improve the visibility of the light emitter and further to improve the freedom of layout of the motor and the like to improve the design of the drug diffusion device.

In order to achieve the above object, the first invention is
A drug carrier that holds the drug,
An electric motor for driving a blower unit for blowing air to the drug holding body to dissipate the drug into the air;
A power supply unit for supplying power to the electric motor;
An apparatus main body accommodating the electric motor and the power supply unit;
A power switch for switching between the supply state and the non-supply state in which the electric power of the electric power supply unit is supplied to the electric motor, or in order to notify surrounding persons by light whether the electric motor is operating or not. A substrate on which the light emitting body for notifying the operation state of
A housing space of the drug holding body is formed together with the device body, and the cover is formed to cover the housing space, and a cover attached to the device body so as to be able to open the housing space when replacing the drug holding body. In the provided drug delivery device,
The cover is attached to the device body so as to be able to open the housing space by pivoting around a support shaft,
The substrate is a flexible substrate extending from the device body to the cover, and the flexible substrate passes through the inside of the device body rather than the spindle.
The back surface of the cover is provided with a substrate holding portion for holding an end of the flexible substrate on the cover side,
The power switch or the operation state notifying light emitter is mounted on an end of the flexible substrate on the cover side and connected to the apparatus main body via the flexible substrate .

  According to this configuration, when electric power is supplied from the electric power supply unit to the electric motor and the blower unit is driven, the medicine holding body is ventilated and the medicine is dissipated in the air. When replacing the drug carrier after use, the cover can be easily replaced by operating the cover so as to open the storage space.

  Further, since the substrate on which the power switch and the operation state notification light emitter are mounted is provided on the cover side, it is possible to omit the space for arranging the substrate, which has conventionally been required on the apparatus body side. As a result, the size of the device body is reduced, and the degree of freedom in the layout of the motor and the power supply unit is improved. As a result, the design of the drug delivery device is improved.

  Further, since the power switch or the portion mounted with the operation state notification light emitter is provided on the cover, the power switch or the operation state notification light emitter is also disposed on the cover side. Therefore, the visibility of the power switch is improved and the operability is also improved. Similarly, the visibility of the operating state notifying light emitter is improved.

Further, although the power switch or the light emitting body for informing the operation state is provided on the cover side, it is not necessary to separately provide a wire for connecting the cover and the apparatus main body side. That is, since the flexible board doubles as the original function as a board for mounting the power switch or the light emitting body for operation state notification on the cover side and the function for electrically connecting the cover and the apparatus main body, the number of parts is reduced. As well as being reduced, assembly workability is improved. Moreover, since it is a flexible substrate, it is possible to follow the rotation of the cover around the support shaft and to eliminate the risk of disconnection.

  In addition, since the flexible substrate is hardly exposed to the outside, damage to the flexible substrate can be suppressed, and the appearance of the medicine diffusion device can be improved.

The second aspect of the present invention,
The power switch or the operating state notifying light source is provided to face the surface of the cover.

As a result, the visibility of the power switch is further improved, and the operability is further improved. In addition, the visibility of the operating state notifying light emitter is further improved .

In a third aspect of the present invention, in the first or second aspect ,
An end of the flexible substrate on the side of the device body is characterized in that the flexible substrate is not fixed to the device body.

  According to this configuration, the end portion on the apparatus main body side of the flexible substrate is not fixed to the apparatus main body and is in a free state, so that it can freely move. As a result, when the cover is rotated, even if the end on the cover side of the flexible substrate moves together with the cover, an excessive force is less likely to act on the flexible substrate.

A fourth invention is according to any one of the first to third inventions,
The cover forms an accommodation space of the power supply unit with the apparatus main body, and can open the accommodation space of the power supply unit when the power supply unit is replaced,
In the state where the cover is closed, a cover back side space surrounded by the back surface of the cover, the accommodation space of the power supply unit, and the accommodation space of the medicine holder is formed,
At least a portion of the substrate on which the power switch or the operation state notifying light emitter is mounted is disposed in the space on the back surface side of the cover.

  According to this configuration, by opening the cover, the substrate moves together with the cover, and both the drug holding body and the storage space of the power supply unit can be opened at one time. The substrate does not get in the way during replacement. That is, a rational layout in which the substrate is placed in the extra space surrounded by the drug holder and the power supply unit can be realized without impairing the convenience of the user.

  According to the first aspect of the invention, at least the portion of the substrate on which the power switch or the operation state notification light emitter is mounted is provided on the cover, so that the operability and visibility of the power switch can be reduced while miniaturizing the device body. In the case where the light emitter is provided, the visibility of the light emitter can be improved. Furthermore, the layout freedom of the motor and the power supply unit can be improved, and the design of the drug diffusion device can be improved.

In addition, a cover is attached to the apparatus body so as to be rotatable around a support shaft, and a power switch or a light emitting body for informing the operation state is connected to the apparatus body via a flexible substrate extending from the apparatus body to the cover. As a result, since the flexible board doubles as the original function as a substrate for mounting the power switch or the light emitting body for notifying the operation state and the function for electrically connecting the cover and the apparatus main body, the number of parts can be reduced. In addition, the assembly workability can be improved. Furthermore, when the cover is turned at the time of replacement of the drug holding body, the risk of disconnection can be eliminated.

In addition, since the flexible substrate passes through the inner side of the device body than the spindle, the flexible substrate is less likely to be exposed to the outside. Thus, damage to the flexible substrate can be suppressed, and the appearance of the medicine diffusion device can be improved.

According to the second invention, since the power switch or the operating state informing emitters provided so as to face the surface of the cover, it is possible to the operability and visibility of the power switch to more favorable, also, The visibility of the operating state notifying light emitter can be further improved .

According to the third aspect of the present invention, the end of the flexible substrate on the side of the device body can be made non-fixed and free from the device body. As a result, when the cover is rotated, even if the end of the flexible substrate on the cover side moves together with the cover, the flexible substrate is less likely to be subjected to an excessive force, and the durability can be improved.

According to the fourth aspect of the present invention, at least the portion of the substrate on which the power switch or the operating state notifying light emitter is mounted is disposed in the space on the back surface side of the cover. It is possible to realize a rational layout in which the substrate is placed in a space without impairing the convenience of the user.

It is the perspective view which looked at the medicine diffusion device concerning an embodiment from the front side. It is the perspective view which looked at a medicine diffusion device from the back side. It is a top view of a medicine diffusion device. It is a bottom view of a medicine diffusion device. It is a front view of a medicine diffusion device. It is a rear view of a medicine diffusion device. It is a left view of a medicine diffusion device. It is the VIII-VIII sectional view taken on the line in FIG. It is the IX-IX sectional view taken on the line in FIG. It is a perspective view of the medicine diffusion device which opened the cover and removed the medicine retention cartridge. It is a XI-XI line sectional view in FIG. It is the perspective view which looked at a medicine holding cartridge from the front side. It is a top view of a medicine holding cartridge. It is a bottom view of a medicine holding cartridge. It is a left view of a medicine maintenance cartridge. It is a front view of a medicine holding cartridge. It is the XVII-XVII sectional view taken on the line in FIG. It is the XVIII-XVIII sectional view taken on the line in FIG.

  Hereinafter, embodiments of the present invention will be described in detail based on the drawings. The following description of the preferred embodiments is merely illustrative in nature, and is not intended to limit the present invention, its applications, or its applications.

  FIG. 1 is a perspective view of a medicine diffusion device 1 according to an embodiment of the present invention as viewed from the front side and from above. The drug delivery device 1 can be attached and used by, for example, a user. The attachment site of the drug diffusion device 1 is the arm or leg of the user, clothes, a belt, etc. For example, it is preferable to use by attaching to the wrist, upper arm, ankle etc. However, the attachment site is limited to these sites It is not a thing.

  The drug diffusion device 1 includes a drug holding cartridge 2 (shown by an imaginary line in FIG. 11) and a device main body 5 to which the drug holding cartridge 2 is detachably mounted. In the description of this embodiment, in order to facilitate the description, as shown in FIGS. 1 to 9, one longitudinal side of the medicine diffusion device 1 is the front side, and the other longitudinal side is the rear side. And when the medicine diffusion device 1 is seen from the front side, let the side which becomes the right be the right, and let the side which becomes the left be the left.

(Configuration of drug holding cartridge 2)
The configuration of the medicine holding cartridge 2 will be described based on FIGS. 12 to 18. The drug holding cartridge 2 includes a case 3 and a drug holding body 4 for holding a drug. The case 3 is a container for containing the drug carrier 4. The drug held by the drug carrier 4 may be any of various drugs having the property of volatilizing at normal temperature, and examples thereof include pest repellents, insecticides, fragrances, disinfectants, deodorants and the like. Among these, only 1 type may be used and 2 or more types may be mixed and used. The drug may be held by being impregnated into the drug carrier 4 or may be held by being attached to the surface of the drug carrier 4. Preferably the drug is a liquid.

  As shown in FIG. 17, the drug holding body 4 is formed of a pleated cloth material which is bent and formed so as to form a continuous waveform. As the cloth material, for example, non-woven fabric, woven fabric and the like can be used, but in addition to these, it is air-permeable and capable of holding a drug (foam material having air-permeable etc.) Well, not particularly limited. The drug is substantially uniformly held throughout the drug carrier 4.

  In this embodiment, for convenience of description, the front side, the rear side, the right side and the left side of the medicine holding cartridge 2 are defined as shown in FIGS. The front side, the rear side, the right side and the left side of the medicine holding cartridge 2 are on the same side as the front side, the rear side, the right side and the left side of the medicine diffusion device 1 in a state where the medicine holding cartridge 2 is attached to the device body 5.

  The drug holding body 4 has a shape close to a substantially positive direction in a plan view, and although the details will be described later, the air blown by the apparatus main body 5 passes downward from above. As shown in FIG. 17, the heights (pleat heights) of the pleats 4b in the predetermined range on the front and rear sides of the drug holding body 4 are the heights of the pleats 4a in the other part, that is, the middle portion in the longitudinal direction. It is set lower than it is. That is, the heights of the pleats 4b at both ends in the continuous direction of the pleats 4a and 4b in the drug holding body 4 are set lower than the heights of the pleats 4a at the intermediate portion in the continuous direction of the pleats 4a and 4b There is.

  In this embodiment, the lower portions of the pleat height on the front side and the rear side of the drug holding body 4 are two by two, but the number of mountains is not limited to this and is set to an arbitrary number be able to. Further, the pleat height on the front side and the rear side of the drug holding body 4 can be set to 1/3 or less, for example, 1/2 of the pleat height of the middle portion in the front-rear direction.

  The case 3 is configured by combining an upper case member 10 and a lower case member 20 both made of a resin material. The lower case member 20 has a bottom wall 21 on which the drug holding body 4 is mounted, and a side wall 22 extending upward from the peripheral edge of the bottom wall 21. The bottom wall portion 21 has a square shape substantially the same as the shape of the bottom surface of the drug holding body 4.

  The upper case member 10 has an upper wall portion 11 and a side wall portion 12 extending downward from the peripheral edge portion of the upper wall portion 11. The upper case member 10 and the lower case member 20 are integrated by fitting the side wall portion 22 of the lower case member 20 inside the side wall portion 12 of the upper case member 10.

  The upper wall portion 11 of the upper case member 10 is disposed so as to cover the drug holding body 4 from above. The upper wall portion 11 of the upper case member 10 is formed so as to bulge upward as a whole such that the longitudinal center portion is at the uppermost position, and from there to the front side and the rear side, the lower side. There is. Thus, of the upper wall portion 11, the wall portions covering the front and rear side walls, that is, the front and rear pleats 4b of the drug holding body 4 are the wall portions of the longitudinal middle portion, ie, the drug holding body 4 It is formed so that it may be located below the wall part which covers the pleat 4a of the longitudinal direction middle part in.

  As shown in FIGS. 12 and 13, the upper wall 11 of the upper case member 10 is formed with a plurality of inflow openings (air circulation holes) 11a, 11a,. ing. Each inflow opening 11 a has a long shape in the front-rear direction of the case 3. The inflow openings 11a, 11a,... Are formed to be spaced apart from each other in the direction intersecting the longitudinal direction of the inflow opening 11a, that is, in the left-right direction. The inflow opening 11 a formed in the central portion of the upper wall 11 is longer in the front-rear direction than the opening 11 b formed on the front side or the rear side of the upper wall 11. The opening 11 b is also for introducing air into the case 3. Further, the inflow opening portion 11a has a wide opening width (dimension in the left-right direction) in the front-rear direction intermediate portion, and the opening width becomes narrower toward the front side and the rear side.

  As shown in FIGS. 12 and 15, a notch 12a is formed at the center in the front-rear direction at the lower end of the left and right side walls 12 of the upper case member 10. As shown in FIG. The width of the notch 12a is narrower toward the top. In the left and right side wall portions 12 of the upper case member 10, side wall openings 12b are formed on the front side and the rear side, respectively.

  As shown in FIG. 14, the bottom wall 21 of the lower case member 20 is formed with an outflow opening 21 a through which the air flowing into the case 3 flows out. The outflow opening 21 a has a shape substantially similar to the outer shape of the bottom wall 21. A cover 21b is provided on the peripheral edge of the outflow opening 21a so as to cover the peripheral edge of the medicine carrier 4 from the downstream side in the air flow direction. The cover 21b is provided over the entire periphery of the peripheral edge of the outflow opening 21a, and has a substantially rectangular frame shape when the case 3 is viewed from below. As a result, the peripheral portion of the drug holding body 4 is covered by the covering portion 21b over the entire circumference and supported from the downstream side in the air flow direction. The covering portion 21 b is for making air less likely to flow in the gap between the inner surface of the case 3 and the peripheral portion of the drug holding body 4.

  In this embodiment, the cover 21b is provided on the peripheral edge of the outflow opening 21a, but not limited to this, the shape of the inflow opening 11a is the same as that of the outflow opening. A covering portion may be provided on the entire periphery of the peripheral edge of the inflow opening 11a so as to cover the peripheral edge of the medicine carrier 4 from the upstream side in the air flow direction. Moreover, you may provide a cover part in both the peripheral part of the opening 21a for outflow, and the peripheral part of the opening 11a for inflow. Further, the covering portion 21b may be provided on a part of the periphery of the outflow opening 21a without being provided, for example, provided only on the part covering the pleats 4b and 4b of the drug holding body 4 It can also be done. Similarly, when the cover is provided on the peripheral edge of the inflow opening 11a, it may be provided on the entire periphery of the peripheral edge of the inflow opening 11a, or may be provided on only a part.

  The covering portion 21b covers the pleats 4b and 4b on the front side and the rear side of the medicine holding member 4 from the downstream side in the air flow direction. That is, the pleats 4b, 4b covered by the cover 21b in the medicine holding body 4 are set to have a lower pleat height than the pleats 4a not covered by the cover 21b. Since the height of the pleats 4 b of the portion covered by the cover portion 21 b in the medicine holding body 4 is lowered, the medicine holding cartridge 2 is miniaturized accordingly.

  In the bottom wall 21 of the lower case member 20, a thin plate 21c extending in the left-right direction and a thin plate 21d extending in the front-rear direction are provided to cross the outflow opening 21a. . The drug holding body 4 is supported from below by the plate-like portions 21c and 21d.

(Configuration of device body 5)
The configuration of the apparatus main body 5 will be described based on FIGS. 1 to 11. As shown in FIG. 8, the device body 5 includes a base member 30, a fan 50 as a blower, an electric motor 51 for driving the fan 50, and a battery (power supply unit) 52 for supplying electric power to the electric motor 51. , 52. The fan 50, the electric motor 51, and the batteries 52, 52 are accommodated in the base member 30 of the device body 5. The battery 52 is, for example, AA batteries or AAA batteries.

  That is, the base member 30 is formed by molding, for example, a resin material, and has a lower plate portion 31 and a side plate portion 32 extending upward from the peripheral edge portion of the lower plate portion 31. is there. The lower surface 31a of the lower plate portion 31 is a mounting surface that contacts the user in a mounted state to the user, and the lower surface 31a is gently curved so that the center in the front-rear direction is at the top. It has a shape that is easy to fit when it contacts, for example, the arm of a person.

  As shown in FIG. 1, at the front end portion of the base member 30, projecting plate portions 33, 33 which respectively project obliquely downward from the left and right end portions are formed. Both end portions of a rod-like portion 34 extending in the left-right direction are fixed to tip end portions in the protruding direction of the protruding plate portions 33, 33, respectively. The rod-like portion 34 is separated from the outer surface of the lower plate portion 31 and the side plate portion 32 of the base member 30. Further, as shown in FIG. 2, the rear end portion of the base member 30 is also provided with projecting plate portions 33, 33 and a rod-like portion 34 similar to the front end portion. A band B (shown by an imaginary line only in FIG. 3) for connecting the drug diffusion device 1 to the user by being wound around the user's arm or the like is connected to the rod-like portions 34, 34. As the band B, a conventionally known one can be used, and for example, a band made of cloth, whose length can be adjusted, and the like can be mentioned. The rod portion 34 on the front side is a first band connecting portion, and the rod portion 34 on the rear side is a second band connecting portion, which constitute an attachment portion for attaching the drug diffusion device 1 to the user There is. Further, the front side rod-shaped portion 34 and the rear side rod-shaped portion 34 are arranged at an interval in the front-rear direction.

  As shown in FIG. 8, an electric motor 51 is fixed to a substantially central portion of the lower plate portion 31 of the base member 30. The output shaft 51a of the electric motor 51 projects upward. The central portion of the fan 50 is integrally fixed to the upper end portion of the output shaft 51a. The fan 50 is a well-known one, and when rotationally driven by the electric motor 51, the fan 50 sucks in air from above and blows air so as to flow out from the side. Further, the base member 30 is provided with an air flow path forming member 53 which is formed to cover the fan 50 from the lower side and the side and to form an air flow path.

  A front battery storage space S1 and a rear battery storage space S2 for storing the batteries 52 in a replaceable manner are formed on the front side and the rear side of the air flow path forming member 53 inside the device main body 5, respectively. An electric motor 51 is disposed between the accommodation space S1 and the rear battery accommodation space S2. Each of the battery storage spaces S1 and S2 has an elongated shape extending in the vicinity of the left and right end portions of the device body 5, and is opened only upward. When the battery 52 is accommodated in each of the battery accommodation spaces S1 and S2, it can be accommodated only from above, and when taking out the battery 52 from each of the battery accommodation spaces S1 and S2, it can be taken out only upward It has become. The dimension in the left-right direction of each battery housing space S1, S2 is set substantially equal to the dimension in the left-right direction of the battery 52, and the dimension in the front-rear direction of each battery housing space S1, S2 is the dimension in the front-rear direction of the battery 52 It is set approximately equal to (outside diameter).

  Above the fan 50, a cartridge accommodating space R for accommodating the medicine holding cartridge 2 including the medicine holding body 4 in an exchangeable manner is formed. The cartridge accommodation space R is a space formed by the apparatus main body 5 and the cover 40 attached to the apparatus main body 5. The cover 40 is formed to cover the cartridge housing space R from above, and the details thereof will be described later. When replacing the drug holding cartridge 2 including the drug holding body 4, the cartridge housing space R is attached to the apparatus main body 5 so as to be openable. It is done.

  The cartridge accommodation space R is formed above the front and rear battery accommodation spaces S1 and S2. The drug holding cartridge 2 housed in the cartridge housing space R is supported from below by the device body 5. Further, as shown in FIG. 10, positioning portions 57, 57 for positioning the medicine holding cartridge 2 are provided on the left and right sides, respectively, inside the apparatus main body 5. The positioning portions 57, 57 are formed in a plate shape extending in the vertical direction, and the upper end portion thereof is fitted in the notch portion 12 a of the case 3 of the medicine holding cartridge 2.

  As also shown in FIGS. 8 and 11, in the front-rear dimension of the cartridge housing space R, the front end portion and the rear end portion of the cartridge housing space R overlap the open portions of the front and rear battery housing spaces S1 and S2, respectively. Is set as. The dimension of the cartridge accommodation space R in the left-right direction is set substantially equal to the dimension of the medicine holding cartridge 2 in the left-right direction, and the dimension of the cartridge accommodation space R in the front-rear direction is substantially equal to the dimension of the medicine holding cartridge 2 in the front-rear direction It is set equally.

  Therefore, in plan view, the rear portion of the battery 52 housed in the front battery housing space S1 overlaps the front portion of the medicine holding cartridge 2 housed in the cartridge housing space R, and is housed in the rear battery housing space S2. The front of the battery 52 overlaps the rear of the medicine holding cartridge 2 housed in the cartridge housing space R. Therefore, when taking out the battery 52 stored in the front battery storage space S1 from the front battery storage space S1, the medicine holding cartridge 2 stored in the cartridge storage space R is positioned on the movement trajectory of the battery 52. At the same time, when taking out the battery 52 stored in the rear battery storage space S2 from the rear battery storage space S2, the medicine holding cartridge 2 stored in the cartridge storage space R is positioned on the movement trajectory of the battery 52. become. That is, the medicine holding cartridge 2 accommodated in the cartridge accommodation space R interferes with any of the battery 52 taken out from the front battery accommodation space S1 and the battery 52 taken out from the rear battery accommodation space S2. The drug holding cartridge 2 housed in the cartridge housing space R is arranged to interfere only with either the battery 52 taken out from the front battery housing space S1 or the battery 52 taken out from the rear battery housing space S2. May be

  Further, as shown in FIG. 8, in the state where the cover 40 is closed, a cover back side space T surrounded by the back side of the cover 40, the rear side battery storage space S2 and the cartridge storage space R is formed. ing.

  A support shaft 35 extending in the left-right direction is provided at the rear end of the base member 30 of the apparatus main body 5. The support shaft 35 is for rotatably supporting the cover 40. Therefore, the cover 40 is attached to the apparatus main body 5 so as to be able to open the cartridge housing space R by rotating around the support shaft 35. ing. The open state of the cover 40 is shown in FIG.

  As shown in FIG. 9, on both left and right sides of the base member 30 of the device main body 5, drug diffusion holes 55 for releasing the air blown to the drug holding body 4 by the fan 50 are respectively formed. The upstream end of the drug diffusion hole 55 communicates with the space in the device body 5 in which the fan 50 is disposed. As shown in FIG. 7, the downstream end opening of the drug diffusion hole 55 is open on the side surface of the base member 30 and is disposed between the front rod portion 34 and the rear rod portion 34. The downstream end opening of the drug diffusion hole 55 is shaped to be long in the front-rear direction so as to be along the lower surface 31 a of the lower plate portion 31 of the base member 30. The front end of the downstream end opening of the drug diffusion hole 55 is located behind the front battery storage space S1, and the rear end of the downstream end opening of the drug discharge hole 55 is in front of the rear battery storage space S2. positioned.

  The drug discharge hole 55 is formed so that a part of the fan 50 can be seen inside the drug discharge hole 55 in a side view shown in FIG. 7. As a result, the air blown from the fan 50 is easily dissipated from the drug diffusion hole 55.

  Further, as shown in FIG. 7, among the edges of the downstream end opening of the drug diffusion hole 55, the upper edge 55 a and the upper edge 55 b extend substantially in the front-rear direction. The lower edge 55b is a first edge located on the side closer to the user when the medicine diffusion device 1 is attached to the user, and the upper edge 55a is farther from the user than the first edge. It is the second edge. The lower edge portion 55b is formed to be positioned higher toward the front side and the rear side. Further, the upper edge portion 55a is formed to be positioned lower toward the front side and the rear side. As a result, the opening width (the dimension in the vertical direction) of the downstream end opening of the drug diffusion hole 55 becomes narrower toward the front side and the rear side, and the longitudinal middle portion becomes wider.

  As shown in the cross-sectional view of FIG. 9, the upper edge 55a of the downstream end opening of the left drug diffusion hole 55 is positioned on the left side, ie, downstream in the air flow direction, than the lower edge 55b. Further, the upper edge 55a of the downstream end opening of the right drug diffusion hole 55 is positioned on the right side of the lower edge 55b, that is, on the downstream side in the air flow direction. As a result, the air that has flowed through the medicine diffusion hole 55 and reached the downstream end opening can easily flow downward of the medicine diffusion device 1 as indicated by the arrow a.

  As shown in FIGS. 1 and 2, the cover 40 is made of, for example, a resin material, and covers both the cartridge housing space R and the front and rear battery housing spaces S1 and S2 from above. It is large in size. Accordingly, the upper surface of the device body 5 is covered by the cover 40 substantially entirely.

  The cover 40 has an upper plate portion 41 and side plate portions 42 extending downward from both left and right side edge portions of the upper plate portion 41. As shown in FIG. 7, the upper plate portion 41 is formed so as to bulge outward of the cartridge accommodation space R, and as a whole, the central portion in the front-rear direction is located at the top as a whole. It is curved to be positioned lower as you go. As shown in FIG. 8, the portion of the case 3 of the medicine holding cartridge 2 covered by the cover 40, that is, the upper wall 11 of the case 3 has a center in the front-rear direction corresponding to the bulging shape of the cover 40. It bulges to be located at the top.

  As shown in FIGS. 1 and 2, the upper plate portion 41 of the cover 40 is formed with a plurality of openings 41a, 41a,... Serving as suction ports for drawing air into the cartridge accommodation space R. The opening 41a of the cover 40 has a shape that is long in the substantially front-rear direction, and thus becomes long in the same direction as the inflow opening 11a of the medicine holding cartridge 2 housed in the cartridge housing space R. The openings 41 a of the cover 40 are formed to be spaced apart from each other in the left-right direction, which is a direction intersecting the longitudinal direction of the openings 41 a.

  Further, through holes 41 c are formed in the upper plate portion 41 of the cover 40 on both left and right sides. The through hole 41 c is also long in the front-rear direction, and is for drawing air into the cartridge accommodation space R.

  Since the cover 40 is located above the device main body 5, the downstream end opening of the drug diffusion hole 55 of the device main body 5 is closer to the opening 41 a of the cover 40 in the attached state to the user of the drug diffusion device 1. It is arranged to be close to the user. As a result, it is possible to supply the air containing the drug to be dissipated from the drug discharge hole 55 toward the user while disposing the suction opening 41a and the drug discharge hole 55 separately. Become.

  As shown in FIGS. 2 and 3 and the like, at the rear end portion of the cover 40, a support portion 43 supported by the support shaft 35 of the apparatus main body 5 is provided. The support portion 43 has a substantially cylindrical shape formed so as to surround the support shaft 35. Although not shown, a support shaft may be provided on the cover 40 and a support may be provided on the apparatus main body 5.

  As shown in FIGS. 10 and 11, an engaging portion 47 is provided at the front end of the cover 40 so as to project downward. An engagement hole 47 a is formed in the engagement portion 47. On the other hand, at the front end portion of the apparatus main body 5, an engagement claw 38 is provided so as to protrude. As shown in FIG. 8 etc., when the cover 40 is in the fully closed state, the engagement claw 38 of the apparatus main body 5 is fitted into the engagement hole 47 a of the cover 40 so that the cover 40 does not rotate in the opening direction. Locked on In order to open the cover 40, the cover 40 and the apparatus main body 5 may be elastically deformed to release the engagement claws 38 of the apparatus main body 5 from the engagement holes 47a of the cover 40 to release the lock.

  As shown in FIG. 2, a power switch installation hole 41 b is formed at the rear of the cover 40. The power switch installation hole 41b has a long shape in the front-rear direction. A power switch 60 capable of sliding in the front-rear direction is provided in the power switch mounting hole 41 b so as to face the surface of the cover 40. Further, an operation lamp 63 is also provided in the power switch installation hole 41 b so as to face the surface of the cover 40.

  That is, in the medicine diffusion device 1, an electric circuit is configured by the batteries 52, 52, the electric motor 51, the power switch 60, the operation lamp 63, and the resistor (not shown). The power switch 60 is a switch for switching between the supply state of supplying the electric power of the batteries 52, 52 to the electric motor 51 and the non-supply state of not supplying. The operation lamp 63 is a light emitting body for informing the surrounding people (including the user) by light whether or not the electric motor 51 is operating, and can be constituted by, for example, an LED or the like. . For example, as disclosed in Japanese Patent Application Laid-Open No. 2011-130742, the resistor is for substantially matching the life of the batteries 52 and 52 with the life of the medicine holding cartridge 2.

  As shown in FIG. 8, the power switch 60 and the operation lamp 63 are mounted on one end of the flexible substrate 62. The flexible substrate 62 is conventionally known, and is a substrate having a pliable film and a conductive layer provided on the film, and can be deformed by a weak force and can be conductive even after being deformed. The conductive state of the layer can be maintained, and moreover, it is configured so as not to break even if it is repeatedly deformed. The power switch 60 and the operation lamp 63 are connected to the electric motor 51 and the battery 52 of the apparatus main body 5 via the flexible substrate 62 and a wire (not shown) extending from the other end of the flexible substrate 62.

  One end portion 62 a of the flexible substrate 62 is fixed on the inner surface of the upper plate portion 41 of the cover 40 on the back side of the power switch installation hole 41 b. More specifically, one end 62 a of the flexible substrate 62 is disposed in the space T on the back side of the cover.

  One end 62a of the flexible substrate 62 is a portion on which the power switch 60 and the operation lamp 63 are mounted, and is reinforced by an epoxy resin containing glass fiber and is thicker and more rigid than other portions. . Thereby, for example, when the user operates the power switch 60, the one end portion 62a of the flexible substrate 62 is not deformed, and the switch operation is not disturbed.

One end 62 a of the flexible substrate 62 is held by a substrate holding portion 48 provided on the back surface of the cover 40. The arrangement position of the substrate holding portion 48 is between the one end portion 62 a of the flexible substrate 62 and the battery 52 on the rear side. The substrate holding portion 48 is formed to cover the one end portion 62 a of the flexible substrate 62 from the back side of the substrate 62 (the side opposite to the side on which the power switch 60 and the like are mounted). As a result, for example, even if the drug diffusion device 1 falls or the like and a shock acts, and the battery 52 pops out, the battery 52 can be prevented from contacting the one end portion 62 a of the flexible substrate 62. The substrate holding portion 48 also has a function of suppressing the battery 52 from coming out by pressing the battery 52 from the top in a state where the cover 40 is closed.
Further, in this embodiment, although the above-mentioned resistor is also mounted on one end portion 62a of the flexible substrate 62, the present invention is not limited to this, and the resistor can be mounted on other portion of the flexible substrate 62. Alternatively, it may be provided in a portion other than the flexible substrate 62 and electrically connected.

  Further, the portion on which the power switch 60 and the operation lamp 63 are mounted may be configured by a substrate other than the flexible substrate 62. In this case, the substrate may be connected to the flexible substrate 62.

  The power switch 60 and the operation lamp 63 may be disposed at positions other than the rear portion of the cover 40, for example, the front portion or the central portion in the front-rear direction, but the flexible substrate The rear of the cover 40 is preferable in consideration of the arrangement of 62.

  The flexible substrate 62 extends toward the base member 30 through the inside of the device body 5 with respect to the spindle 35 of the device body 5. The other end of the flexible substrate 62 reaches below the rear battery storage space S <b> 2 inside the base member 30. The end of the flexible substrate 62 on the device body 5 side is not fixed to the device body 5, that is, not fixed to the device body 5, and is free. The length of the flexible substrate 62 is set to a sufficient length so that the end of the flexible substrate 62 on the device body 5 side does not come off the device body 5 when the cover 40 is turned.

  The flexible substrate 62 is disposed so as to pass through the central portion in the left-right direction of the device body 5. This is because the power switch 60 and the operation lamp 63 are disposed at the center of the cover 40 in the left-right direction. If the power switch 60 and the operation lamp 63 are to be provided on the device body 5 side, it is generally assumed that the power switch 60 and the operation lamp 63 are provided on either the left or right side of the device body 5. In such a configuration, the substrate for mounting the power switch 60 and the operation lamp 63 needs to be disposed close to either the left or the right of the apparatus main body 5. In this respect, in the present embodiment, since the power switch 60 and the operation lamp 63 are not provided on the device body 5 side, the arrangement position of the flexible substrate 62 on the device body 5 side is not limited.

  Although both the power switch 60 and the operation lamp 63 are provided on the cover 4 in the above embodiment, the present invention is not limited to this. Only one of the power switch 60 and the operation lamp 63 may be provided on the cover 4. Also, the power switch 60 and the operation lamp 63 may be provided separately.

(Operation of drug diffusion device 1)
Next, the operation of the medicine diffusion device 1 will be described. The drug diffusion device 1 is attached to the arm or the like of the user using a band B shown by an imaginary line in FIG. Then, when the power switch 60 is slid to “ON”, the electric power of the batteries 52 is supplied to the electric motor 51 and the operation lamp 63 to operate the electric motor 51 and the operation lamp 63 is turned on. Since the power switch 60 is provided on the cover 40, the visibility of the power switch 60 is improved when the apparatus main body 5 is miniaturized and the cover 40 is enlarged to be able to accommodate the large drug carrier 4 At the same time, the operability also becomes good. Similarly, since the drive lamp 63 is provided on the cover 40, the visibility of the drive lamp 63 is improved.

  When the electric motor 51 operates, the fan 50 is rotationally driven to suck air from above the fan 50 and cause it to flow out from the side. The air above the cover 40 is drawn into the cartridge accommodation space R from the opening 41a and the through hole 41c formed in the upper plate portion 41 of the cover 40 by the flow of the air as shown by the arrow B in FIG. . Since the drug holding cartridge 2 is stored in the cartridge containing space R, the sucked air flows toward the drug holding cartridge 2 and is formed at the upper portion of the case 3 of the drug holding cartridge 2. It flows into the inside of the case 3 from the opening 11 a and the opening 11 b. The air that has flowed into the inside of the case 3 flows downward because the outflow opening 21a (shown in FIG. 14) is formed in the lower part of the case 3, and while passing through the medicine holding body 4 It becomes air containing a drug and flows out of the case 3 through the outflow opening 21a.

  When the air flows into the case 3, as shown in FIG. 14, the peripheral portion of the drug holding body 4 is covered from the downstream side in the air flow direction by the covering portion 21 b of the case 3. It becomes difficult to flow toward the gap between the and the peripheral portion of the drug support 4. As a result, the air flowing through the gap between the inner surface of the case 3 and the peripheral portion of the drug holding member 4, that is, the air containing no drug is reduced, so that the reduction of the efficacy due to the drug is suppressed.

  As described above, the height of the pleats 4b in the drug holding body 4 is reduced, and the pleats 4b having a low height are covered by the covering portion 21b. Therefore, the pleats 4b in the medicine carrier 4 are portions where air can not easily pass as compared with the pleats 4a. Therefore, even if the height of the pleats 4 b is lowered to narrow the air passage area in that portion, the decrease in efficacy is hardly a problem.

  The air containing the medicine which has flowed out of the case 3 from the outflow opening 21a of the medicine holding cartridge 2 flows into the medicine diffusion holes 55, 55 on the left and right of the device body 5, as shown by the arrow a in FIG. Then, the drug is released from the downstream end opening of each drug release hole 55 to the outside. At this time, among the edges of the downstream end opening of each drug discharge hole 55, the upper edge 55a remote from the user is located downstream of the lower edge 55b closer to the user in the air flow direction. Therefore, it is easy for the drug-containing air to flow toward the user. This makes it easier for the drug to reach the user, thereby further enhancing the efficacy of the drug. Further, since each drug discharge hole 55 extends along the lower surface 31 a of the device body 5, the air containing the drug is dissipated from a wide range of the device body 5.

  Further, since the downstream end opening of each drug diffusion hole 55 is disposed between the rod portion 34 on the front side and the rod portion 34 on the rear side of the device main body 5, the band B and the rod portions 34, 34 The air containing the drug is not inhibited and the air containing the medicine is smoothly dissipated in the desired direction. From the above, drug efficacy is sufficiently obtained.

(How to replace the drug holding cartridge 2)
Next, the procedure for replacing the medicine holding cartridge 2 will be described. In the medicine diffusion device 1 according to this embodiment, a resistor is provided in the electric circuit to substantially match the life of the medicine holding cartridge 2 with the life of the batteries 52, 52. Therefore, when replacing the medicine holding cartridge 2, the battery It is assumed that 52 and 52 are also exchanged simultaneously.

  First, the engagement claws 38 of the apparatus body 5 are disengaged from the engagement holes 47 a of the cover 40 to release the lock of the cover 40. Then, the cover 40 is pivoted upward around the support shaft 35 to open the cartridge housing space R. At this time, since the power switch 60 and the operation lamp 63 are provided on the flexible substrate 62, the cover 40 can be pivoted smoothly and at the same time the one end 62a of the flexible substrate 62 is moved. The substrate 62 does not get in the way when replacing 52. That is, in this embodiment, the rational layout in which the one end portion 62a of the flexible substrate 62 is disposed in the cover back side space T which is an extra space surrounded by the drug holding cartridge 2 and the battery 52 is convenient for the user. It is realized without losing the sex.

  After the cover 40 is opened, the medicine holding cartridge 2 stored in the cartridge storage space R is removed. Since the medicine holding cartridge 2 is only placed on the apparatus main body 5, the removal work can be easily performed.

  Further, the batteries 52, 52 stored in the front and rear battery storage spaces S1, S2 are taken out. The drug holding cartridge 2 housed in the cartridge housing space R is arranged so as to interfere with any of the battery 52 taken out from the front battery housing space S1 and the battery 52 taken out from the rear battery housing space S2. If the holding cartridge 2 is not removed first, the battery 52 interferes with the medicine holding cartridge 2. As a result, the user can easily notice that the drug holding cartridge 2 needs to be replaced, and simultaneous replacement of the batteries 52 and 52 and the drug holding cartridge 2 can be promoted.

  After taking out the batteries 52, 52, the new batteries 52, 52 are accommodated in the front and rear battery accommodation spaces S1, S2. Thereafter, the new medicine holding cartridge 2 is housed in the cartridge housing space R. At this time, the extending direction of the openings 41a, 41a, ... of the cover 40 and the extending direction of the inflow opening 11a of the medicine holding cartridge 2 are substantially the same direction. The medicine holding cartridge 2 may be directed so that the extending direction of the medicine substantially coincides with the extending direction of the openings 41a, 41a,... Of the cover 40. It can be easily determined.

  Further, since the cover 4 is connected to the apparatus main body 5 via the support shaft 35 in the open state of the cover 40, the direction in which the openings 41a, 41a, ... of the cover 40 extend and the cartridge accommodation space R of the apparatus main body 5 The relationship does not change, and the direction of the medicine holding cartridge 2 can be easily determined on the basis of the extending direction of the openings 41a, 41a,.

  Further, since the bulging shape of the cover 40 corresponds to the bulging shape of the case 3 of the drug holding cartridge 2, the direction of the drug holding cartridge 2 can be easily determined using the bulging shapes of both. Becomes possible.

  When the medicine holding cartridge 2 is accommodated in the cartridge accommodation space R, the positioning portions 57 of the device main body 5 are fitted into the notch 12 a of the case 3 of the medicine holding cartridge 2. Thereby, the medicine holding cartridge 2 is held at the predetermined position.

  Thereafter, the cover 40 is pivoted about the support shaft 35 and closed, and the engagement claw 38 of the apparatus main body 5 is fitted into the engagement hole 47 a of the cover 40 to lock the cover 40. In this state, the inner surface of the cover 40 presses the drug holding cartridge 2 from above, and rattling of the drug holding cartridge 2 is suppressed.

  Further, since the end of the flexible substrate 62 on the cover 40 side is fixed to the cover 40 and the flexible substrate 62 passes through the inside of the support shaft 35, the flexible substrate 62 is pushed along with the opening / closing operation of the cover 40. And will be pulled. At this time, the device main body 5 side of the flexible substrate 62 is in a free state with respect to the device main body 5, so that the flexible substrate 62 can be easily moved when the cover 40 is opened and closed. Can be

(Action effect)
As described above, since the power switch 60 and the operation lamp 63 are provided on the cover 40, the operability and the visibility of the power switch 60 are good when the apparatus body 5 is miniaturized and the cover 40 is enlarged. In addition, the visibility of the operation lamp 63 can be improved.
In addition, since one end 62a of the substrate 62 on which the power switch 60 and the operation lamp 63 are mounted is provided on the cover 4 side, a space for providing the substrate conventionally required on the device body 5 side may be omitted. It will be possible. As a result, the size of the device body 5 is reduced, and the degree of freedom in the layout of the battery 52 etc. is improved. As a result, the design of the drug delivery device 1 is improved.

  Further, the cover 40 is attached to the apparatus main body 5 so as to be rotatable around the support shaft 35, and the power switch 60 and the operation lamp 63 are connected to the apparatus main body 5 via the flexible substrate 62. When the cover 40 is turned at the time of replacement, the risk of disconnection can be eliminated.

  Further, since the flexible substrate 62 passes through the inner side of the apparatus main body 5 with respect to the support shaft 35, the flexible substrate 62 is difficult to be exposed to the outside. Thus, damage to the flexible substrate 62 can be suppressed, and the appearance of the medicine diffusion device 1 can be improved.

  Further, the end of the flexible substrate 52 on the side of the device body 5 is not fixed to the device body 5 to be free. Thereby, when rotating the cover 40, even if the end of the flexible substrate 62 on the cover 40 side moves together with the cover 40, the flexible substrate 62 is less likely to exert an unreasonable force, and the durability is improved. be able to.

  In addition, since the drug holding cartridge 2 housed in the cartridge housing space R interferes with the batteries 52, 52 taken out from the front and rear battery housing spaces S1, S2, when the batteries 52, 52 are replaced The drug holding cartridge 2 can also be urged to be replaced at the same time, and it is possible to prevent in advance that the drug's efficacy has been reduced without the user's notice.

  Further, since the electric motor 51 is disposed between the front battery storage space S1 and the rear battery storage space S2, the weight balance of the medicine diffusion device 1 can be improved.

  Also, the batteries 52, 52 can be disposed under the drug diffusion device 1 to achieve a low center of gravity. In this case, since the medicine holding cartridge 2 reliably interferes with at least a part of the battery 52 at the time of replacement, the exchange of the medicine holding cartridge 2 can be effectively promoted.

  In addition, since the cover 40 formed to cover both the cartridge accommodation space R and the battery accommodation spaces S1 and S2 is attached to the apparatus main body 5, the cartridge accommodation space R and the battery accommodation space S1 are opened by opening the cover 40. , S2 can be opened, and both the drug holding cartridge 2 and the batteries 52, 52 can be easily replaced. The number of batteries 52 is not limited to two, and may be one or three or more.

  Further, since the cover portion 21b covering the peripheral portion of the drug holding body 4 of the drug holding cartridge 2 in the air flow direction is provided in the case 3, circulation of air from the gap between the drug holding body 4 and the inner surface of the case 3 is suppressed. Can improve their effectiveness. And since the height of the pleat 4b covered by the cover part 21b in the medicine holding body 4 is set low, the medicine holding body 4 can be made smaller and the medicine holding cartridge 2 can be miniaturized without greatly reducing the efficacy. it can.

  Further, since the outer shape of the case 3 is made to correspond to the pleat height of the drug holding body 4, the drug holding cartridge 2 can be made compact.

  When the drug holding cartridge 2 is attached to the apparatus main body 5, the extending directions of the openings 41a, 41a,... Of the cover 40 and the extending direction of the inflow opening 11a of the drug holding cartridge 2 are substantially the same. The orientation of the cartridge can be determined intuitively and easily, and even when the drug holding cartridge 2 is replaced for the first time, it can be easily replaced without any confusion.

  Further, since the upper edge 55a of the downstream end opening of the drug discharge hole 55 of the device body 5 is positioned downstream of the lower edge 55b in the air flow direction, the drug dissipated from the downstream end opening of the drug discharge hole 55 It becomes easy for the air containing air to flow toward the user. This makes it easier for the drug to reach the user, and as a result, the efficacy of the drug can be enhanced.

  The drug diffusion device 1 can be used, for example, as it is placed or attached to a bag or the like.

  The embodiments described above are merely illustrative in every respect and should not be construed as limiting. Furthermore, all variations and modifications that fall within the equivalent scope of the claims fall within the scope of the present invention.

  As described above, the present invention can be used, for example, attached to the user.

Reference Signs List 1 drug diffusion device 2 drug holding cartridge 4 drug holder 5 device main body 35 spindle 40 cover 50 fan (air blower)
51 electric motor 52 battery (power supply unit)
60 power switch 62 flexible substrate 63 operation lamp (light emitter for notifying operation condition)
R Cartridge storage space S1, S2 Battery storage space

Claims (4)

A drug carrier that holds the drug,
An electric motor for driving a blower unit for blowing air to the drug holding body to dissipate the drug into the air;
A power supply unit for supplying power to the electric motor;
An apparatus main body accommodating the electric motor and the power supply unit;
A power switch for switching between the supply state and the non-supply state in which the electric power of the electric power supply unit is supplied to the electric motor, or in order to notify surrounding persons by light whether the electric motor is operating or not. A substrate on which the light emitting body for notifying the operation state of
A housing space of the drug holding body is formed together with the device body, and the cover is formed to cover the housing space, and a cover attached to the device body so as to be able to open the housing space when replacing the drug holding body. In the provided drug delivery device,
The cover is attached to the device body so as to be able to open the housing space by pivoting around a support shaft,
The substrate is a flexible substrate extending from the device body to the cover, and the flexible substrate passes through the inside of the device body rather than the spindle.
The back surface of the cover is provided with a substrate holding portion for holding an end of the flexible substrate on the cover side,
The chemical power dissipation device characterized in that the power switch or the light emitting body for informing the operation state is mounted on an end of the flexible substrate on the cover side and connected to the apparatus main body via the flexible substrate. . In the drug delivery device according to claim 1 ,
A drug diffusion device characterized in that the power switch or the operation state notification light source is provided to face the surface of the cover. The drug delivery device according to claim 1 or 2
An end of the flexible substrate on the side of the device main body is in a non-fixed state with respect to the device main body. The drug delivery device according to any one of claims 1 to 3 .
The cover forms an accommodation space of the power supply unit with the apparatus main body, and can open the accommodation space of the power supply unit when the power supply unit is replaced,
In the state where the cover is closed, a cover back side space surrounded by the back surface of the cover, the accommodation space of the power supply unit, and the accommodation space of the medicine holder is formed,
A drug dissipation device characterized in that at least a portion of the substrate on which the power switch or the light emitting body for informing the operation state is mounted is disposed in the space on the back side of the cover.

Images